Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. [electronic resource]
Producer: 20071018Description: 4350-7 p. digitalISSN:- 1527-7755
- Antineoplastic Agents -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Line, Tumor
- Cisplatin -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Drug Screening Assays, Antitumor
- Female
- Gene Expression Profiling
- Glutamates -- pharmacology
- Guanine -- analogs & derivatives
- Humans
- Lung Neoplasms -- drug therapy
- Oligonucleotide Array Sequence Analysis
- Ovarian Neoplasms -- drug therapy
- Patient Selection
- Pemetrexed
- Predictive Value of Tests
- Regression Analysis
- Reproducibility of Results
- Sensitivity and Specificity
No physical items for this record
Publication Type: Journal Article; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.